US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

1.68

-0.0600-3.45%

Pre-market: 1.680.00000.00%04:04 EDT

Volume:97.06K

Turnover:164.66K

Market Cap:2.50M

PE:-0.01

High:1.75

Open:1.75

Low:1.61

Close:1.74

52wk High:524.00

52wk Low:1.43

Shares:1.49M

Float Shares:1.48M

Volume Ratio:0.44

T/O Rate:6.58%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-175.9200

EPS(LYR):-303.4772

ROE:-114.61%

ROA:-51.35%

PB:0.22

PE(LYR):-0.01

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere

BUZZ-Clearmind Medicine rises after alcohol addiction drug shows safety in early trial

Clearmind Medicine Inc - Third Cohort Results Show High Safety Profile for Cmnd-100 With No Serious Adverse Events

THOMSON REUTERS

Clearmind Medicine Inc - Phase I/Iia Trial Evaluates Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Cmnd-100

THOMSON REUTERS

Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

BRIEF-Clearmind Medicine Files Patent Application In India For Next-Gen Psychedelic Compounds To Treat Mental Health Disorders

Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

THOMSON REUTERS

Clearmind Medicine reports successful ongoing treatment in CMND-100 trial

Clearmind Medicine reports ongoing Phase I/IIa CMND-100 trial treatment at U.S. sites for alcohol use disorder

Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in Its FDA-Approved Cmnd-100 Phase I/Iia Clinical Trial for Alcohol Use Disorder

THOMSON REUTERS

Clearmind Medicine reports publication of six Hong Kong patents for PEA-psychedelic combination therapies

Clearmind Medicine announces Hong Kong patent filing for depression therapy

Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

THOMSON REUTERS

BUZZ-SciSparc jumps as unit files patent for obesity, fatty liver treatment

SciSparc-Controlled NeuroThera Labs Publishes PCT Patent for MEAI-PEA Weight Loss and MASLD Therapy

BUZZ-Clearmind rises after advancing trial of alcohol-use disorder drug

Clearmind advances recruitment for CMND-100 trial’s third cohort

Clearmind Medicine advances third-cohort enrollment for Phase I/IIa CMND-100 alcohol use disorder trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CMND/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CMND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","market":"US","secType":"STK","nameCN":"Clearmind Medicine, Inc.","latestPrice":1.68,"timestamp":1787601600000,"preClose":1.74,"halted":0,"volume":97062,"hourTrading":{"tag":"盘前","latestPrice":1.68,"preClose":1.68,"latestTime":"04:04 EDT","volume":214,"amount":359.52,"timestamp":1787645066436,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03448275862068969,"floatShares":1475956,"shares":1485551,"eps":-175.92,"marketStatus":"Pre-Mkt","change":-0.06,"latestTime":"08-25 05:00:20 EDT","open":1.75,"high":1.75,"low":1.61,"amount":164659.2672018,"amplitude":0.08046,"askPrice":1.75,"askSize":500,"bidPrice":1.56,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-175.92,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"listingDate":1668142800000,"exchange":"NASDAQ","adjPreClose":1.68,"preHourTrading":{"tag":"盘前","latestPrice":1.68,"preClose":1.68,"latestTime":"04:04 EDT","volume":214,"amount":359.52,"timestamp":1787645066436,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.72,"preClose":1.68,"latestTime":"19:32 EDT","volume":6225,"amount":10937.1265,"timestamp":1787614379363,"change":0.04,"changeRate":0.02381,"amplitude":0.053571},"volumeRatio":0.44110263401364985},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","floatShares":1475956,"roa":"-51.35%","roe":"-114.61%","lyrEps":-303.47721,"volumeRatio":0.44110263401364985,"shares":1485551,"dividePrice":0,"high":1.75,"amplitude":0.08046,"preClose":1.74,"low":1.61,"week52Low":1.43,"pbRate":"0.22","week52High":524,"institutionHeld":0,"latestPrice":1.68,"committee":-0.666667,"eps":-175.92,"divideRate":0,"volume":97062,"delay":0,"ttmEps":-175.92,"open":1.75,"prevYearClose":18.1,"prevWeekClose":1.74,"prevMonthClose":1.69,"prevQuarterClose":2.2,"fiveDayClose":1.89,"twentyDayClose":1.62,"sixtyDayClose":2.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-21","symbol":"CMND","defaultRemindTime":1779370200000,"type":"split","dateTimestamp":1779336000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-12-15","symbol":"CMND","defaultRemindTime":1765809000000,"type":"split","dateTimestamp":1765774800000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-11-28","symbol":"CMND","defaultRemindTime":1701181800000,"type":"split","dateTimestamp":1701147600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMND\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMND","date":"2026-08-21","current":-0.00955,"percent":0.941224,"low":-79.538912,"twenty":-1.516375,"median":-0.919213,"eighty":-0.470511,"high":-0.132425,"avg":-3.703769,"sd":10.946061,"marketCap":2570003},"quantilePoints":[{"date":"2021-08-27","current":-66.570612,"twenty":-61.834695,"median":-18.523034,"eighty":-5.327909,"marketCap":22871673.05},{"date":"2021-09-03","current":-77.809807,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":26985610.07},{"date":"2021-09-10","current":-70.893378,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24346632.12},{"date":"2021-09-17","current":-71.757932,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24430331.48},{"date":"2021-09-24","current":-73.487039,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":25125635.9},{"date":"2021-10-01","current":-18.935815,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24276713.03},{"date":"2021-10-08","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23471549.77},{"date":"2021-10-15","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23660527.38},{"date":"2021-10-22","current":-17.781192,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23366442.66},{"date":"2021-10-29","current":-16.626569,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":21791515.03},{"date":"2021-11-05","current":-17.319343,"twenty":-61.834695,"median":-18.935815,"eighty":-5.327909,"marketCap":22614497.39},{"date":"2021-11-12","current":-16.16472,"twenty":-61.834695,"median":-18.473966,"eighty":-5.327909,"marketCap":20907283.62},{"date":"2021-11-19","current":-15.933796,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":20493935.46},{"date":"2021-11-26","current":-17.319343,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":22007930.87},{"date":"2021-12-03","current":-16.16472,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20516830.56},{"date":"2021-12-10","current":-15.933796,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20363701.64},{"date":"2021-12-17","current":-14.548248,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":18448575.82},{"date":"2021-12-23","current":-13.393625,"twenty":-61.834695,"median":-17.781192,"eighty":-5.327909,"marketCap":16986524.41},{"date":"2021-12-31","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17198471.74},{"date":"2022-01-07","current":-12.700852,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16298591.95},{"date":"2022-01-14","current":-12.239002,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":15851627.15},{"date":"2022-01-21","current":-10.853455,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14077636.85},{"date":"2022-01-28","current":-12.931776,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16468260.15},{"date":"2022-02-04","current":-14.548248,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18518085.11},{"date":"2022-02-11","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18343985.21},{"date":"2022-02-18","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18253458.39},{"date":"2022-02-25","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17082383.51},{"date":"2022-03-04","current":-4.943147,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14402278.55},{"date":"2022-03-11","current":-4.741385,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":13870054.34},{"date":"2022-03-18","current":-4.489184,"twenty":-61.834695,"median":-17.582743,"eighty":-5.327909,"marketCap":13226105.9},{"date":"2022-03-25","current":-2.663476,"twenty":-61.834695,"median":-17.550268,"eighty":-5.327909,"marketCap":12172123.95},{"date":"2022-04-01","current":-2.696359,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":12315499.88},{"date":"2022-04-08","current":-3.090948,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":14024131.41},{"date":"2022-04-14","current":-2.433299,"twenty":-61.834695,"median":-17.088418,"eighty":-5.327909,"marketCap":11016821.23},{"date":"2022-04-22","current":-2.30177,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":10351738.45},{"date":"2022-04-29","current":-2.564829,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":11431112.19},{"date":"2022-05-06","current":-2.531947,"twenty":-61.834695,"median":-16.511107,"eighty":-5.327909,"marketCap":11240443.79},{"date":"2022-05-13","current":-2.433299,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10747956.2},{"date":"2022-05-20","current":-2.466182,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10972362.04},{"date":"2022-05-27","current":-2.334652,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10462796.86},{"date":"2022-06-03","current":-2.400417,"twenty":-61.834695,"median":-15.933796,"eighty":-5.327909,"marketCap":10896966.45},{"date":"2022-06-10","current":-2.30177,"twenty":-61.834695,"median":-15.702871,"eighty":-5.327909,"marketCap":10273199.15},{"date":"2022-06-17","current":-2.400417,"twenty":-61.834695,"median":-15.471947,"eighty":-5.327909,"marketCap":10503138.41},{"date":"2022-06-24","current":-2.367534,"twenty":-61.744414,"median":-15.471947,"eighty":-5.327909,"marketCap":10469452.66},{"date":"2022-07-01","current":-1.560974,"twenty":-60.553176,"median":-15.147663,"eighty":-5.327909,"marketCap":10729626.02},{"date":"2022-07-08","current":-1.560974,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10710469.08},{"date":"2022-07-15","current":-1.605574,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10950633.46},{"date":"2022-07-22","current":-1.516375,"twenty":-57.130437,"median":-15.147663,"eighty":-5.327909,"marketCap":10468944.81},{"date":"2022-07-29","current":-1.427176,"twenty":-56.195971,"median":-15.147663,"eighty":-5.327909,"marketCap":9885259.74},{"date":"2022-08-05","current":-1.471776,"twenty":-55.226088,"median":-14.779173,"eighty":-5.327909,"marketCap":10092669.27},{"date":"2022-08-12","current":-1.427176,"twenty":-54.0772,"median":-14.548248,"eighty":-5.327909,"marketCap":9901792.86},{"date":"2022-08-19","current":-1.427176,"twenty":-43.677709,"median":-14.317323,"eighty":-5.327909,"marketCap":9745576.64},{"date":"2022-08-26","current":-1.382577,"twenty":-41.597849,"median":-14.317323,"eighty":-5.327909,"marketCap":9442770.76},{"date":"2022-09-02","current":-1.271079,"twenty":-41.597849,"median":-14.086399,"eighty":-5.327909,"marketCap":8615042.98},{"date":"2022-09-09","current":-1.427176,"twenty":-41.597849,"median":-14.086399,"eighty":-5.135307,"marketCap":9711214.67},{"date":"2022-09-16","current":-1.360278,"twenty":-41.597849,"median":-13.855475,"eighty":-5.135307,"marketCap":9096403.07},{"date":"2022-09-23","current":-1.248779,"twenty":-41.597849,"median":-13.62455,"eighty":-5.135307,"marketCap":8172150.47},{"date":"2022-09-30","current":-0.929266,"twenty":-41.597849,"median":-13.393625,"eighty":-5.135307,"marketCap":6512507.37},{"date":"2022-10-07","current":-1.087585,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7646662.48},{"date":"2022-10-14","current":-1.080702,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7496705.29},{"date":"2022-10-21","current":-1.049293,"twenty":-41.597849,"median":-13.278163,"eighty":-5.074202,"marketCap":7357917.44},{"date":"2022-10-28","current":-1.165881,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":8234273.61},{"date":"2022-11-04","current":-1.08907,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":7753472.39},{"date":"2022-11-11","current":-1.082212,"twenty":-38.270012,"median":-12.931776,"eighty":-5.074202,"marketCap":7833552.75},{"date":"2022-11-18","current":-1.935818,"twenty":-37.438053,"median":-12.700852,"eighty":-5.074202,"marketCap":13927482.09},{"date":"2022-11-25","current":-1.650458,"twenty":-37.438053,"median":-12.585389,"eighty":-5.074202,"marketCap":11873272.72},{"date":"2022-12-02","current":-1.27255,"twenty":-37.438053,"median":-12.008078,"eighty":-5.074202,"marketCap":9091614.07},{"date":"2022-12-09","current":-1.079739,"twenty":-37.438053,"median":-11.682462,"eighty":-4.943147,"marketCap":7625598.02},{"date":"2022-12-16","current":-1.40109,"twenty":-37.438053,"median":-11.587771,"eighty":-4.791826,"marketCap":9845331.19},{"date":"2022-12-23","current":-1.375382,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":9740512.57},{"date":"2022-12-30","current":-1.141438,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":8114893.38},{"date":"2023-01-06","current":-1.118301,"twenty":-37.438053,"median":-11.587771,"eighty":-4.539624,"marketCap":7989125.08},{"date":"2023-01-13","current":-1.62475,"twenty":-37.438053,"median":-11.587771,"eighty":-4.186477,"marketCap":11656520.47},{"date":"2023-01-20","current":-1.568192,"twenty":-37.438053,"median":-10.853455,"eighty":-4.136102,"marketCap":11253776.1},{"date":"2023-01-27","current":-1.33682,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9661985.46},{"date":"2023-02-03","current":-1.332642,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9371651.68},{"date":"2023-02-10","current":-1.393097,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9812413.93},{"date":"2023-02-17","current":-1.272187,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8867258.2},{"date":"2023-02-24","current":-1.240431,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8572078.87},{"date":"2023-03-03","current":-1.10085,"twenty":-37.438053,"median":-9.227851,"eighty":-3.551938,"marketCap":7606207.65},{"date":"2023-03-10","current":-1.198293,"twenty":-37.438053,"median":-9.227851,"eighty":-3.45974,"marketCap":8185550.86},{"date":"2023-03-17","current":-1.120516,"twenty":-37.438053,"median":-9.227851,"eighty":-2.755547,"marketCap":7980631.72},{"date":"2023-03-24","current":-0.916786,"twenty":-37.438053,"median":-9.227851,"eighty":-2.696359,"marketCap":6519731.67},{"date":"2023-03-31","current":-0.417647,"twenty":-37.438053,"median":-9.227851,"eighty":-2.624017,"marketCap":3018701.27},{"date":"2023-04-06","current":-0.132425,"twenty":-37.438053,"median":-9.227851,"eighty":-2.584558,"marketCap":960449.73},{"date":"2023-04-14","current":-0.500779,"twenty":-37.438053,"median":-9.227851,"eighty":-2.531947,"marketCap":3666478.25},{"date":"2023-04-21","current":-0.622397,"twenty":-37.438053,"median":-9.227851,"eighty":-2.499064,"marketCap":4520895.91},{"date":"2023-04-28","current":-0.579473,"twenty":-37.438053,"median":-9.227851,"eighty":-2.453029,"marketCap":4166925.01},{"date":"2023-05-05","current":-0.550857,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":3966371.91},{"date":"2023-05-12","current":-0.558011,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":4046484.45},{"date":"2023-05-19","current":-0.572319,"twenty":-37.438053,"median":-9.227851,"eighty":-2.400417,"marketCap":4145445.66},{"date":"2023-05-26","current":-0.58694,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":4210059.56},{"date":"2023-06-02","current":-0.550709,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":3999105.96},{"date":"2023-06-09","current":-0.514478,"twenty":-34.942175,"median":-9.227851,"eighty":-2.321499,"marketCap":3767591.98},{"date":"2023-06-16","current":-0.531091,"twenty":-33.278257,"median":-9.227851,"eighty":-2.30177,"marketCap":3748293.76},{"date":"2023-06-23","current":-0.458354,"twenty":-33.278257,"median":-9.227851,"eighty":-2.28204,"marketCap":3234938.84},{"date":"2023-06-30","current":-0.478478,"twenty":-30.295333,"median":-9.227851,"eighty":-2.043589,"marketCap":3376966.22},{"date":"2023-07-07","current":-0.436578,"twenty":-26.688751,"median":-9.227851,"eighty":-1.802136,"marketCap":3081249.21},{"date":"2023-07-14","current":-0.436972,"twenty":-26.688751,"median":-8.613576,"eighty":-1.651163,"marketCap":3084034.14},{"date":"2023-07-21","current":-0.43717,"twenty":-26.688751,"median":-8.613576,"eighty":-1.562418,"marketCap":3085429.18},{"date":"2023-07-28","current":-0.458608,"twenty":-26.688751,"median":-8.613576,"eighty":-1.560974,"marketCap":3236727.75},{"date":"2023-08-04","current":-0.483799,"twenty":-26.688751,"median":-8.613576,"eighty":-1.558522,"marketCap":3414522.56},{"date":"2023-08-11","current":-0.383836,"twenty":-26.688751,"median":-6.222948,"eighty":-1.516375,"marketCap":2709008.42},{"date":"2023-08-18","current":-0.372906,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2631871.39},{"date":"2023-08-25","current":-0.39406,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2781166.24},{"date":"2023-09-01","current":-0.447028,"twenty":-26.688751,"median":-5.926622,"eighty":-1.427176,"marketCap":3155002.59},{"date":"2023-09-08","current":-0.442472,"twenty":-19.813329,"median":-5.926622,"eighty":-1.427176,"marketCap":3122844.46},{"date":"2023-09-15","current":-0.187109,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":1320569.3},{"date":"2023-09-22","current":-0.388305,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":2475737.22},{"date":"2023-09-29","current":-0.315336,"twenty":-19.430851,"median":-5.926622,"eighty":-1.415486,"marketCap":2010507.36},{"date":"2023-10-06","current":-0.365327,"twenty":-19.430851,"median":-5.926622,"eighty":-1.395726,"marketCap":2329231.67},{"date":"2023-10-13","current":-0.367265,"twenty":-19.430851,"median":-5.926622,"eighty":-1.382577,"marketCap":2341589.46},{"date":"2023-10-20","current":-0.334674,"twenty":-19.430851,"median":-5.926622,"eighty":-1.368527,"marketCap":2133796.18},{"date":"2023-10-27","current":-0.290523,"twenty":-19.430851,"median":-5.926622,"eighty":-1.366813,"marketCap":1852300.65},{"date":"2023-11-03","current":-0.316281,"twenty":-19.430851,"median":-5.926622,"eighty":-1.360278,"marketCap":2016523.46},{"date":"2023-11-10","current":-0.325261,"twenty":-19.430851,"median":-5.390754,"eighty":-1.337978,"marketCap":2073784.82},{"date":"2023-11-17","current":-0.300361,"twenty":-19.430851,"median":-5.330934,"eighty":-1.337515,"marketCap":1915028.46},{"date":"2023-11-24","current":-0.302508,"twenty":-19.430851,"median":-5.327909,"eighty":-1.335149,"marketCap":1928712.73},{"date":"2023-12-01","current":-0.350938,"twenty":-19.430851,"median":-5.327909,"eighty":-1.296306,"marketCap":2237493.37},{"date":"2023-12-08","current":-0.980569,"twenty":-19.430851,"median":-5.327909,"eighty":-1.274244,"marketCap":6251864.25},{"date":"2023-12-15","current":-0.736628,"twenty":-19.430851,"median":-5.327909,"eighty":-1.271301,"marketCap":4696557.28},{"date":"2023-12-22","current":-0.812759,"twenty":-19.430851,"median":-5.327909,"eighty":-1.259672,"marketCap":5181946.56},{"date":"2023-12-29","current":-0.682126,"twenty":-19.430851,"median":-5.327909,"eighty":-1.237797,"marketCap":4349066.88},{"date":"2024-01-05","current":-0.630384,"twenty":-19.430851,"median":-5.327909,"eighty":-1.211461,"marketCap":4019166.25},{"date":"2024-01-12","current":-0.436686,"twenty":-19.430851,"median":-5.327909,"eighty":-1.179486,"marketCap":2784200.42},{"date":"2024-01-19","current":-0.561866,"twenty":-19.430851,"median":-5.327909,"eighty":-1.15795,"marketCap":3582314.16},{"date":"2024-01-26","current":-0.716167,"twenty":-19.430851,"median":-5.327909,"eighty":-1.132962,"marketCap":4566100.74},{"date":"2024-02-02","current":-0.652747,"twenty":-19.430851,"median":-5.327909,"eighty":-1.116775,"marketCap":5627224.65},{"date":"2024-02-09","current":-0.504935,"twenty":-19.430851,"median":-5.327909,"eighty":-1.1005,"marketCap":4352964.23},{"date":"2024-02-16","current":-0.519849,"twenty":-19.430851,"median":-5.327909,"eighty":-1.096168,"marketCap":4481532.37},{"date":"2024-02-23","current":-0.672729,"twenty":-18.473966,"median":-5.327909,"eighty":-1.087585,"marketCap":5799482.19},{"date":"2024-03-01","current":-0.54179,"twenty":-18.473966,"median":-5.327909,"eighty":-1.08191,"marketCap":4670679.77},{"date":"2024-03-08","current":-0.505134,"twenty":-18.473966,"median":-5.327909,"eighty":-1.079739,"marketCap":4354677.58},{"date":"2024-03-15","current":-0.435211,"twenty":-18.473966,"median":-5.327909,"eighty":-1.064778,"marketCap":3751886.19},{"date":"2024-03-22","current":-0.499967,"twenty":-18.473966,"median":-5.327909,"eighty":-1.046318,"marketCap":4044318},{"date":"2024-03-28","current":-0.471743,"twenty":-18.473966,"median":-5.327909,"eighty":-0.975962,"marketCap":3816009},{"date":"2024-04-05","current":-0.463679,"twenty":-18.473966,"median":-5.327909,"eighty":-0.890377,"marketCap":3750779},{"date":"2024-04-12","current":-0.516095,"twenty":-18.473966,"median":-5.327909,"eighty":-0.810049,"marketCap":4174780},{"date":"2024-04-19","current":-0.475009,"twenty":-18.473966,"median":-5.327909,"eighty":-0.7392,"marketCap":3842428},{"date":"2024-04-26","current":-0.483839,"twenty":-18.473966,"median":-5.327909,"eighty":-0.711567,"marketCap":3913856},{"date":"2024-05-03","current":-0.471784,"twenty":-18.473966,"median":-5.327909,"eighty":-0.652729,"marketCap":3816336},{"date":"2024-05-10","current":-0.604799,"twenty":-18.473966,"median":-5.327909,"eighty":-0.644215,"marketCap":4892320},{"date":"2024-05-17","current":-0.520127,"twenty":-18.473966,"median":-5.327909,"eighty":-0.61393,"marketCap":4207395},{"date":"2024-05-24","current":-0.453599,"twenty":-18.473966,"median":-5.327909,"eighty":-0.600881,"marketCap":3669240},{"date":"2024-05-31","current":-0.459647,"twenty":-18.473966,"median":-5.327909,"eighty":-0.594105,"marketCap":3718163},{"date":"2024-06-07","current":-0.420053,"twenty":-18.473966,"median":-5.109555,"eighty":-0.586092,"marketCap":3397879},{"date":"2024-06-14","current":-0.435455,"twenty":-18.473966,"median":-5.074202,"eighty":-0.577013,"marketCap":3522470},{"date":"2024-06-21","current":-0.612279,"twenty":-18.473966,"median":-5.074202,"eighty":-0.572319,"marketCap":4237588},{"date":"2024-06-28","current":-0.64098,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":4436225},{"date":"2024-07-05","current":-0.727082,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5032136},{"date":"2024-07-12","current":-0.770133,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5330091},{"date":"2024-07-15","current":-0.813184,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5628047},{"date":"2024-08-02","current":-0.717515,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":4965924},{"date":"2024-08-09","current":-0.569229,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":3939633},{"date":"2024-08-16","current":-0.545311,"twenty":-19.331844,"median":-5.074202,"eighty":-0.558549,"marketCap":3774102},{"date":"2024-08-23","current":-0.660114,"twenty":-19.331844,"median":-5.008674,"eighty":-0.558011,"marketCap":4568650},{"date":"2024-08-30","current":-0.631413,"twenty":-19.331844,"median":-4.791826,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-06","current":-0.617063,"twenty":-19.331844,"median":-4.539624,"eighty":-0.558011,"marketCap":4270694},{"date":"2024-09-13","current":-0.631413,"twenty":-19.331844,"median":-4.09773,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-20","current":-0.506022,"twenty":-19.331844,"median":-4.059359,"eighty":-0.552636,"marketCap":4270694},{"date":"2024-09-27","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-04","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-11","current":-0.653648,"twenty":-19.331844,"median":-4.04729,"eighty":-0.550947,"marketCap":5516615},{"date":"2024-10-18","current":-0.634423,"twenty":-19.331844,"median":-2.811447,"eighty":-0.550947,"marketCap":5354362},{"date":"2024-10-25","current":-0.74016,"twenty":-19.331844,"median":-2.696359,"eighty":-0.550947,"marketCap":6246755},{"date":"2024-10-31","current":-0.70171,"twenty":-19.331844,"median":-2.614152,"eighty":-0.550947,"marketCap":5922249},{"date":"2024-11-08","current":-0.672873,"twenty":-19.430851,"median":-2.531947,"eighty":-0.550857,"marketCap":5678869},{"date":"2024-11-15","current":-0.706517,"twenty":-19.430851,"median":-2.499064,"eighty":-0.550857,"marketCap":5962812},{"date":"2024-11-22","current":-0.644036,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5435488},{"date":"2024-11-29","current":-0.624811,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5273235},{"date":"2024-12-06","current":-0.639229,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5394925},{"date":"2024-12-13","current":-0.70171,"twenty":-19.430851,"median":-2.400417,"eighty":-0.550857,"marketCap":5922249},{"date":"2024-12-20","current":-0.571942,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":4827038},{"date":"2024-12-27","current":-0.749773,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":6327882},{"date":"2025-01-03","current":-0.696904,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5881685},{"date":"2025-01-10","current":-0.692098,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5841122},{"date":"2025-01-17","current":-0.730548,"twenty":-19.430851,"median":-2.153798,"eighty":-0.550857,"marketCap":6165629},{"date":"2025-01-24","current":-1.150202,"twenty":-19.430851,"median":-1.874119,"eighty":-0.550857,"marketCap":6043939},{"date":"2025-01-31","current":-1.042129,"twenty":-19.430851,"median":-1.662503,"eighty":-0.550857,"marketCap":5476052},{"date":"2025-02-07","current":-1.160721,"twenty":-19.430851,"median":-1.581046,"eighty":-0.550857,"marketCap":6099215},{"date":"2025-02-14","current":-1.13637,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5971260},{"date":"2025-02-21","current":-1.038967,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5459438},{"date":"2025-02-28","current":-0.990265,"twenty":-19.430851,"median":-1.541199,"eighty":-0.550857,"marketCap":5203526},{"date":"2025-03-07","current":-0.900979,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4734356},{"date":"2025-03-14","current":-0.917213,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4819660},{"date":"2025-03-21","current":-1.211596,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":6007699},{"date":"2025-03-28","current":-1.08733,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-04-04","current":-1.066619,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-04-11","current":-0.966947,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":4794606},{"date":"2025-04-17","current":-1.004486,"twenty":-19.430851,"median":-1.424416,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-04-25","current":-1.014841,"twenty":-19.430851,"median":-1.40109,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-05-02","current":-1.056263,"twenty":-19.430851,"median":-1.382577,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-05-09","current":-1.011735,"twenty":-19.430851,"median":-1.375382,"eighty":-0.550857,"marketCap":5016685},{"date":"2025-05-16","current":-1.004486,"twenty":-19.430851,"median":-1.366813,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-05-23","current":-1.035552,"twenty":-19.430851,"median":-1.360278,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-05-30","current":-1.001379,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4965338},{"date":"2025-06-06","current":-0.973316,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4826185},{"date":"2025-06-13","current":-0.909542,"twenty":-19.430851,"median":-1.332642,"eighty":-0.550857,"marketCap":4396917},{"date":"2025-06-20","current":-0.913472,"twenty":-19.430851,"median":-1.295818,"eighty":-0.550857,"marketCap":4415915},{"date":"2025-06-27","current":-0.936415,"twenty":-19.430851,"median":-1.273609,"eighty":-0.550857,"marketCap":4526827},{"date":"2025-07-03","current":-1.168394,"twenty":-19.430851,"median":-1.261673,"eighty":-0.550857,"marketCap":5648264},{"date":"2025-07-11","current":-1.040933,"twenty":-19.430851,"median":-1.240431,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-07-18","current":-1.072798,"twenty":-18.473966,"median":-1.211461,"eighty":-0.550857,"marketCap":5186133},{"date":"2025-07-25","current":-1.094042,"twenty":-18.243042,"median":-1.202815,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-08-01","current":-1.062177,"twenty":-18.012117,"median":-1.178715,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-08","current":-1.08342,"twenty":-17.781192,"median":-1.163301,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-15","current":-1.08342,"twenty":-17.615217,"median":-1.153532,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-22","current":-1.062177,"twenty":-17.615217,"median":-1.142724,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-29","current":-1.08342,"twenty":-17.615217,"median":-1.133121,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-09-05","current":-1.083951,"twenty":-17.615217,"median":-1.119324,"eighty":-0.550857,"marketCap":5240049},{"date":"2025-09-12","current":-1.115286,"twenty":-17.615217,"median":-1.118135,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-09-19","current":-1.348445,"twenty":-17.589237,"median":-1.118135,"eighty":-0.550857,"marketCap":5466441},{"date":"2025-09-26","current":-1.429352,"twenty":-17.319343,"median":-1.118135,"eighty":-0.550857,"marketCap":5794427},{"date":"2025-10-03","current":-1.375414,"twenty":-16.996048,"median":-1.118135,"eighty":-0.550857,"marketCap":5575769},{"date":"2025-10-10","current":-1.29626,"twenty":-16.765124,"median":-1.118135,"eighty":-0.550857,"marketCap":5254889},{"date":"2025-10-17","current":-1.277382,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5178359},{"date":"2025-10-24","current":-1.324577,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5369684},{"date":"2025-10-31","current":-1.222905,"twenty":-15.610501,"median":-1.118135,"eighty":-0.550857,"marketCap":4957515},{"date":"2025-11-07","current":-0.999602,"twenty":-14.779173,"median":-1.11003,"eighty":-0.550857,"marketCap":4052272},{"date":"2025-11-14","current":-0.466831,"twenty":-14.455878,"median":-1.100951,"eighty":-0.550765,"marketCap":1892481},{"date":"2025-11-21","current":-0.268071,"twenty":-14.224953,"median":-1.099975,"eighty":-0.546197,"marketCap":1086728},{"date":"2025-11-28","current":-0.24222,"twenty":-14.086399,"median":-1.095371,"eighty":-0.543703,"marketCap":981932},{"date":"2025-12-05","current":-0.673835,"twenty":-13.62455,"median":-1.094042,"eighty":-0.543703,"marketCap":2731651},{"date":"2025-12-12","current":-1.06106,"twenty":-13.393625,"median":-1.088758,"eighty":-0.543703,"marketCap":4301415},{"date":"2025-12-19","current":-0.965609,"twenty":-13.162701,"median":-1.087521,"eighty":-0.543703,"marketCap":3914467},{"date":"2025-12-26","current":-0.84722,"twenty":-13.162701,"median":-1.085641,"eighty":-0.543703,"marketCap":3434532},{"date":"2026-01-02","current":-0.669637,"twenty":-12.700852,"median":-1.08342,"eighty":-0.543703,"marketCap":2714630},{"date":"2026-01-09","current":-0.899015,"twenty":-12.146632,"median":-1.08342,"eighty":-0.543703,"marketCap":3644504},{"date":"2026-01-16","current":-0.973008,"twenty":-11.587771,"median":-1.080702,"eighty":-0.543703,"marketCap":3944463},{"date":"2026-01-23","current":-1.049901,"twenty":-11.587771,"median":-1.079739,"eighty":-0.543703,"marketCap":4049449},{"date":"2026-01-30","current":-0.851586,"twenty":-11.587771,"median":-1.073308,"eighty":-0.543703,"marketCap":3284553},{"date":"2026-02-06","current":-0.563836,"twenty":-8.613576,"median":-1.072243,"eighty":-0.543703,"marketCap":2174704},{"date":"2026-02-13","current":-0.423849,"twenty":-8.613576,"median":-1.066619,"eighty":-0.541026,"marketCap":1634777},{"date":"2026-02-20","current":-0.577021,"twenty":-8.613576,"median":-1.066037,"eighty":-0.537847,"marketCap":2225559},{"date":"2026-02-27","current":-0.53514,"twenty":-8.613576,"median":-1.062177,"eighty":-0.536549,"marketCap":2064026},{"date":"2026-03-06","current":-0.502566,"twenty":-8.613576,"median":-1.05906,"eighty":-0.536549,"marketCap":1938390},{"date":"2026-03-13","current":-0.385627,"twenty":-4.943147,"median":-1.056151,"eighty":-0.53281,"marketCap":1487355},{"date":"2026-03-20","current":-0.206114,"twenty":-4.77165,"median":-1.051024,"eighty":-0.530164,"marketCap":1368585},{"date":"2026-03-27","current":-0.231847,"twenty":-4.428656,"median":-1.04883,"eighty":-0.52897,"marketCap":1539450},{"date":"2026-04-02","current":-0.339748,"twenty":-3.99487,"median":-1.046113,"eighty":-0.523835,"marketCap":2255910},{"date":"2026-04-10","current":-0.377498,"twenty":-2.748971,"median":-1.042127,"eighty":-0.520127,"marketCap":2506567},{"date":"2026-04-17","current":-0.262518,"twenty":-2.696359,"median":-1.040933,"eighty":-0.5179,"marketCap":1743108},{"date":"2026-04-24","current":-0.257359,"twenty":-2.597711,"median":-1.035552,"eighty":-0.514478,"marketCap":1708852},{"date":"2026-05-01","current":-0.224108,"twenty":-2.531947,"median":-1.031531,"eighty":-0.511783,"marketCap":1488065},{"date":"2026-05-08","current":-0.86327,"twenty":-2.485911,"median":-1.024161,"eighty":-0.510296,"marketCap":5732064},{"date":"2026-05-15","current":-0.811243,"twenty":-2.433299,"median":-1.014273,"eighty":-0.510296,"marketCap":5386612},{"date":"2026-05-22","current":-0.377536,"twenty":-2.433299,"median":-1.008005,"eighty":-0.505681,"marketCap":2506821},{"date":"2026-05-29","current":-0.376002,"twenty":-2.400417,"median":-1.004486,"eighty":-0.504039,"marketCap":2496630},{"date":"2026-06-05","current":-0.446598,"twenty":-2.367534,"median":-0.999455,"eighty":-0.499967,"marketCap":2965386},{"date":"2026-06-12","current":-0.51259,"twenty":-2.367534,"median":-0.994596,"eighty":-0.498651,"marketCap":3403570},{"date":"2026-06-18","current":-0.404845,"twenty":-2.321499,"median":-0.991077,"eighty":-0.492739,"marketCap":3199763},{"date":"2026-06-26","current":-0.468013,"twenty":-2.30177,"median":-0.980602,"eighty":-0.49207,"marketCap":3699021},{"date":"2026-07-02","current":-0.432301,"twenty":-2.262311,"median":-0.977044,"eighty":-0.488105,"marketCap":3416767},{"date":"2026-07-10","current":-0.389071,"twenty":-1.976951,"median":-0.969308,"eighty":-0.483839,"marketCap":3075090},{"date":"2026-07-17","current":-0.374035,"twenty":-1.699795,"median":-0.957532,"eighty":-0.482232,"marketCap":2956246},{"date":"2026-07-24","current":-0.312009,"twenty":-1.620915,"median":-0.952708,"eighty":-0.478963,"marketCap":2466014},{"date":"2026-07-31","current":-0.30449,"twenty":-1.560974,"median":-0.941592,"eighty":-0.477791,"marketCap":2406592},{"date":"2026-08-07","current":-0.328925,"twenty":-1.560974,"median":-0.934845,"eighty":-0.474646,"marketCap":2599714},{"date":"2026-08-14","current":-0.347721,"twenty":-1.557909,"median":-0.925121,"eighty":-0.472163,"marketCap":2748269},{"date":"2026-08-21","current":-0.325166,"twenty":-1.516375,"median":-0.919213,"eighty":-0.470511,"marketCap":2570003}],"updateTime":1787642191617},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMND\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627441678","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere","url":"https://stock-news.laohu8.com/highlight/detail?id=2627441678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627441678?lang=en_us&edition=fundamental","pubTime":"2026-04-14 21:15","pubTimestamp":1776172541,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, TravereWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:/","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL6N40X0IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLL","ACI","BEZ","JNJ","TSLT","NEM","TSLQ","GLMD","NNOX","SPOT","TLA","CRDO","AAL","TSLG","HL","UAL","NWMX","TESL","DAL","KMX","BE","GRCE","CMND","CWVX","CDE","EAF","TSLA","TVTX","CMPS","CRWG","SPOG","TSLW","AU","AVXL","FRDU","CAT","DOW","LCID","BLK","F","LUV","GM","AVNS","HOTH","GSAT","TE","ORCU","CRWV","WMG","ORCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627484443","title":"BUZZ-Clearmind Medicine rises after alcohol addiction drug shows safety in early trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627484443","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627484443?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:44","pubTimestamp":1776167077,"startTime":"0","endTime":"0","summary":"BUZZ-Clearmind Medicine rises after alcohol addiction drug shows safety in early trial** Shares of biotech firm Clearmind Medicine CMND.O shares rise 30.83% to $1.87 premarket** Co says its experimental oral drug CMND-100 is being tested for alcohol use disorder, a condition where people struggle to control heavy drinking** Says the drug met the main goal of safety in an early-stage clinical trial, with no serious side effects reported** Adds the treatment was well tolerated, including at the highest dose tested so far** Says the international study is testing the drug in people with moderate to severe alcohol use disorder and supports further development** As of last close, stock down ~21% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4N40X15J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627443358","title":"Clearmind Medicine Inc - Third Cohort Results Show High Safety Profile for Cmnd-100 With No Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2627443358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627443358?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:32","pubTimestamp":1776166320,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUA802YNW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627443330","title":"Clearmind Medicine Inc - Phase I/Iia Trial Evaluates Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Cmnd-100","url":"https://stock-news.laohu8.com/highlight/detail?id=2627443330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627443330?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:32","pubTimestamp":1776166320,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUA802YNW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627443296","title":"Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2627443296","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627443296?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:32","pubTimestamp":1776166320,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, April  14, 2026 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on the discovery and development","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/14/3273236/0/en/Clearmind-Medicine-s-CMND-100-Meets-Primary-Endpoint-in-FDA-Approved-Phase-I-IIa-Clinical-Trial-for-Alcohol-Use-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4588","BK4007","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624502136","title":"Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2624502136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624502136?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:55","pubTimestamp":1775138153,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on treatment completion, a publicati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-completes-treatment-follow-up-for-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-completes-treatment-follow-up-for-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623310630","title":"Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2623310630","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623310630?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:32","pubTimestamp":1774873920,"startTime":"0","endTime":"0","summary":"Company completed treatment in four additional participate at its Israel clinical site Vancouver, Canada, March  30, 2026 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264626/0/en/Clearmind-Medicine-Announces-Successful-Completion-of-Treatment-and-Follow-up-for-18-Participants-in-its-Ongoing-Phase-I-IIa-Clinical-Trial-of-CMND-100-for-Alcohol-Use-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622825094","title":"BRIEF-Clearmind Medicine Files Patent Application In India For Next-Gen Psychedelic Compounds To Treat Mental Health Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2622825094","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622825094?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:45","pubTimestamp":1774611912,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Files Patent Application In India For Next-Gen Psychedelic Compounds To Treat Mental Health DisordersClearmind Medicine Inc CMND.O:CLEARMIND MEDICINE FILES PATENT APPLICATION ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F02M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622259368","title":"Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2622259368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622259368?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:33","pubTimestamp":1774611206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F02M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620622358","title":"Clearmind Medicine reports successful ongoing treatment in CMND-100 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2620622358","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620622358?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:56","pubTimestamp":1773924961,"startTime":"0","endTime":"0","summary":"The company states: “Clearmind Medicine (CMND) announced the successful continuation of treatment of participants in the third cohort of its ongoin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-reports-successful-ongoing-treatment-in-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-reports-successful-ongoing-treatment-in-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620228264","title":"Clearmind Medicine reports ongoing Phase I/IIa CMND-100 trial treatment at U.S. sites for alcohol use disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228264","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228264?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:45","pubTimestamp":1773924315,"startTime":"0","endTime":"0","summary":"Clearmind reported continued treatment of participants in the third cohort of its FDA-approved Phase I/IIa clinical trial of CMND-100, an oral MEAI-based drug candidate being studied for Alcohol Use Disorder.The multinational, multicenter study is evaluating safety, tolerability, pharmacokinetics, and preliminary efficacy in patients with moderate to severe Alcohol Use Disorder.Ongoing treatment at Yale University and Johns Hopkins University has proceeded with no serious adverse events reported to date.Clearmind did not specify that new results have been presented or provide a timeline for future presentation of results.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL6wyTZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","CMND","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","BK4585","BK4007","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620228469","title":"Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in Its FDA-Approved Cmnd-100 Phase I/Iia Clinical Trial for Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228469?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:45","pubTimestamp":1773924300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUA4GL10M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620342080","title":"Clearmind Medicine reports publication of six Hong Kong patents for PEA-psychedelic combination therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2620342080","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620342080?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:15","pubTimestamp":1773753327,"startTime":"0","endTime":"0","summary":"Clearmind Medicine reports publication of six Hong Kong patents for PEA-psychedelic combination therapies               Clearmind Medicine said six patents were published in Hong Kong covering combina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL48vkFz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4007","LU0314104364.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4585","BK4588","CMND","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619624194","title":"Clearmind Medicine announces Hong Kong patent filing for depression therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2619624194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619624194?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:52","pubTimestamp":1773402753,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced the filing of a patent application with the Intellectual Property Department in Hong Kong, for a combination th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-hong-kong-patent-filing-for-depression-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-hong-kong-patent-filing-for-depression-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619191760","title":"Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2619191760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619191760?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:45","pubTimestamp":1773402314,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nTUA71YFYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618013106","title":"BUZZ-SciSparc jumps as unit files patent for obesity, fatty liver treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2618013106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618013106?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:05","pubTimestamp":1773317117,"startTime":"0","endTime":"0","summary":"BUZZ-SciSparc jumps as unit files patent for obesity, fatty liver treatment** Shares of Israel-based drug developer SciSparc SPRC.O surge 34% to $5.21 premarket** Co says its majority-owned unit NeuroThera Labs filed an international patent for a new combination drug aimed at obesity and metabolic liver disease** Treatment combines MEAI and PEA, developed with Clearmind Medicine CMND.O, co says** Targets obesity and MASLD, a condition where excess fat builds up in the liver and disrupts metabolism; MASLD was earlier known as fatty liver disease - SPRC** Co says therapy could be a safer, cheaper alternative to GLP-1 weight-loss drugs, which can cause side effects** Shares up ~82% in 2025  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4N40016A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618131671","title":"SciSparc-Controlled NeuroThera Labs Publishes PCT Patent for MEAI-PEA Weight Loss and MASLD Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131671?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:55","pubTimestamp":1773316529,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief on March 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL7h30yC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4139","BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618407169","title":"BUZZ-Clearmind rises after advancing trial of alcohol-use disorder drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2618407169","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618407169?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:21","pubTimestamp":1773235282,"startTime":"0","endTime":"0","summary":"BUZZ-Clearmind rises after advancing trial of alcohol-use disorder drug** Shares of biotech company Clearmind Medicine CMND.O rise 10% to $1.10 premarket** Co says it has begun enrolling participants in the third stage of its ongoing study for CMND100, an experimental drug for alcohol use disorder** The condition is marked by difficulty controlling drinking despite harmful consequences; CMND100 aims to reduce cravings without causing hallucinations - CMND** Co says move follows earlier studies showing the drug was safe and welltolerated** Adds study sites include Yale University, Johns Hopkins University and Tel Aviv Sourasky Medical Center** Shares fell ~97% in 2025","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ1AQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618940706","title":"Clearmind advances recruitment for CMND-100 trial’s third cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940706?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:10","pubTimestamp":1773234638,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced the continuation of participant enrollment for the third cohort of its ongoing FDA-approved Phase I/IIa clinica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-advances-recruitment-for-cmnd-100-trials-third-cohort-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-advances-recruitment-for-cmnd-100-trials-third-cohort-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4007","CMND","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618406519","title":"Clearmind Medicine advances third-cohort enrollment for Phase I/IIa CMND-100 alcohol use disorder trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618406519","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618406519?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:07","pubTimestamp":1773234439,"startTime":"0","endTime":"0","summary":"Clearmind said it is continuing enrollment for the third cohort of an FDA-approved Phase I/IIa trial of CMND-100, an oral MEAI-based candidate being studied for alcohol use disorder. Positive topline results from the second cohort have already been presented, and the company said these data showed continued safety and tolerability. Clearmind said its Data and Safety Monitoring Board reviewed the cohort data and approved proceeding to the next phase. The multinational, multicenter study is designed to assess safety, tolerability, pharmacokinetics and preliminary efficacy in patients with moderate to severe alcohol use disorder. Recruitment for the third cohort is taking place at Yale, Johns Hopkins and Tel Aviv Sourasky Medical Center.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDLc5V2qk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","BK4112","BK4585","CMND","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","IE00BKPKM429.USD","BK4007","LU2210149790.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":124,"code":"91000000","status":"200"}]}}